Overview

Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses

Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
The metabolic effect of three different doses of insulin aspart and human insulin are investigated with the euglycaemic glucose clamp technique.
Phase:
Phase 1
Details
Lead Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Long-Acting